Abstract
Medication overuse headache (MOH) leads to high disability and poor quality of life; the debate on value and method of detoxification is still open, even more at the present time with new preventive treatments available. The aim of this study is to estimate the effectiveness of detoxification in multi-resistant chronic migraine (CM) with MOH patients who start prophylaxes Anti-CGRP monoclonal antibodies (mAb).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
